Samsara BioCapital as of June 30, 2021
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 48 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Graphite Bio | 28.2 | $228M | 7.4M | 30.73 | |
| Nkarta (NKTX) | 8.0 | $65M | 2.0M | 31.69 | |
| Novavax (NVAX) | 6.0 | $49M | 229k | 212.30 | |
| Chinook Therapeutics | 5.5 | $45M | 3.2M | 14.12 | |
| Instil Bio | 5.1 | $41M | 2.1M | 19.32 | |
| Forma Therapeutics Hldgs | 4.8 | $39M | 1.6M | 24.89 | |
| Centessa Pharmaceuticals Spons Ads (CNTA) | 4.2 | $34M | 1.5M | 22.21 | |
| Sutro Biopharma (STRO) | 3.8 | $31M | 1.7M | 18.59 | |
| Recursion Pharmaceuticals (RXRX) | 3.5 | $28M | 776k | 36.50 | |
| Rain Therapeutics | 3.1 | $25M | 1.6M | 15.54 | |
| Allakos (ALLK) | 2.4 | $20M | 229k | 85.37 | |
| Janux Therapeutics (JANX) | 1.9 | $15M | 608k | 24.95 | |
| Springworks Therapeutics (SWTX) | 1.7 | $14M | 170k | 82.41 | |
| Aclaris Therapeutics (ACRS) | 1.7 | $14M | 794k | 17.56 | |
| Iveric Bio | 1.7 | $13M | 2.1M | 6.31 | |
| Intercept Pharmaceuticals In | 1.6 | $13M | 641k | 19.97 | |
| Elevation Oncology (ELEV) | 1.6 | $13M | 932k | 13.57 | |
| Bolt Biotherapeutics (BOLT) | 1.4 | $11M | 738k | 15.46 | |
| Syros Pharmaceuticals | 1.3 | $11M | 2.2M | 4.84 | |
| Viracta Therapeutics (VIRX) | 1.0 | $8.1M | 711k | 11.34 | |
| Verona Pharma Spons Ads (VRNA) | 0.9 | $7.3M | 1.1M | 6.54 | |
| Decibel Therapeutics | 0.9 | $7.1M | 826k | 8.60 | |
| Aeglea Biotherapeutics | 0.8 | $6.2M | 884k | 6.96 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $5.9M | 300k | 19.58 | |
| Bctg Acquisition Corp | 0.7 | $5.7M | 500k | 11.38 | |
| Jiya Acquisition Corp | 0.6 | $5.0M | 507k | 9.94 | |
| Day One Biopharmaceuticals I (DAWN) | 0.6 | $4.6M | 203k | 22.77 | |
| Equillium (EQ) | 0.5 | $4.3M | 738k | 5.89 | |
| Eyepoint Pharmaceuticals (EYPT) | 0.5 | $4.0M | 450k | 8.99 | |
| Avadel Pharmaceuticals Spons Adr (AVDL) | 0.5 | $3.7M | 549k | 6.73 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $3.5M | 289k | 12.26 | |
| Albireo Pharma | 0.4 | $3.5M | 100k | 35.18 | |
| Atreca Inc Cl A (BCEL) | 0.4 | $3.4M | 397k | 8.52 | |
| Kala Pharmaceuticals | 0.4 | $3.2M | 601k | 5.30 | |
| Bcls Acquisition Corp | 0.4 | $3.2M | 300k | 10.53 | |
| Consonance Hfw Acquisition C | 0.4 | $3.1M | 300k | 10.40 | |
| Immunocore Holdings Spons Ads (IMCR) | 0.3 | $2.5M | 64k | 39.05 | |
| Alpine Immune Sciences (ALPN) | 0.3 | $2.5M | 275k | 9.00 | |
| Odonate Therapeutics Ord | 0.3 | $2.4M | 700k | 3.49 | |
| Vistagen Therapeutics | 0.3 | $2.3M | 733k | 3.15 | |
| Lifesci Acquisition Ii Corp | 0.2 | $2.0M | 200k | 10.00 | |
| Kronos Bio (KRON) | 0.2 | $1.9M | 78k | 23.95 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $1.8M | 41k | 44.29 | |
| Allovir (ALVR) | 0.2 | $1.6M | 82k | 19.74 | |
| BioNTech SE Spons Ads (BNTX) | 0.2 | $1.3M | 5.8k | 223.86 | |
| Ngm Biopharmaceuticals (NGM) | 0.0 | $359k | 18k | 19.70 | |
| Catabasis Pharmaceuticals Ord | 0.0 | $317k | 150k | 2.11 | |
| Amarin Corp Spons Adr New (AMRN) | 0.0 | $110k | 25k | 4.40 |
